Published in Psychol Assess on March 01, 2007
Reliability and validity of the alcohol short index of problems and a newly constructed drug short index of problems. J Stud Alcohol Drugs (2009) 1.45
Responses to novelty and vulnerability to cocaine addiction: contribution of a multi-symptomatic animal model. Cold Spring Harb Perspect Med (2012) 1.07
Recent status scores for version 6 of the Addiction Severity Index (ASI-6). Addiction (2011) 1.04
Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone. J Gen Intern Med (2010) 0.90
Modeling the impact of age and sex on a dimension of poly-substance use in adolescence: a longitudinal study from 11- to 17-years-old. Drug Alcohol Depend (2010) 0.87
Measures of outcome for stimulant trials: ACTTION recommendations and research agenda. Drug Alcohol Depend (2015) 0.82
Addiction Severity Index (ASI) summary scores: comparison of the Recent Status Scores of the ASI-6 and the Composite Scores of the ASI-5. J Subst Abuse Treat (2013) 0.79
Social adjustment of women with and without a substance-abusing partner. J Psychoactive Drugs (2014) 0.75
Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA (2008) 3.64
A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology (2005) 3.53
Developing adaptive treatment strategies in substance abuse research. Drug Alcohol Depend (2006) 2.98
Initial evidence for the reliability and validity of a "Lite" version of the Addiction Severity Index. Drug Alcohol Depend (2006) 2.89
Causal mediation analyses with rank preserving models. Biometrics (2007) 2.67
Effects of an intensive street-level police intervention on syringe exchange program use in Philadelphia, PA. Am J Public Health (2005) 2.49
The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes. Arch Gen Psychiatry (2005) 2.37
Prescription OxyContin abuse among patients entering addiction treatment. Am J Psychiatry (2007) 2.07
The availability of web sites offering to sell opioid medications without prescriptions. Am J Psychiatry (2006) 1.93
The effectiveness of telephone-based continuing care in the clinical management of alcohol and cocaine use disorders: 12-month outcomes. J Consult Clin Psychol (2004) 1.82
A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend (2004) 1.75
A randomized trial of audio computer and in-person interview to assess HIV risk among drug and alcohol users in Rio De Janeiro, Brazil. J Subst Abuse Treat (2006) 1.72
A randomized, controlled study of treatment for alcohol dependence in patients awaiting liver transplantation. Liver Transpl (2011) 1.69
Extended telephone-based continuing care for alcohol dependence: 24-month outcomes and subgroup analyses. Addiction (2011) 1.68
Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis. J Womens Health (Larchmt) (2008) 1.67
Multidimensional assessment of nicotine dependence in adolescents. Drug Alcohol Depend (2005) 1.56
The relationship between alcohol and individual differences variables on attitudes and behavioral skills relevant to sexual health among heterosexual young adult men. Arch Sex Behav (2004) 1.53
Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend (2003) 1.50
A randomized trial of extended telephone-based continuing care for alcohol dependence: within-treatment substance use outcomes. J Consult Clin Psychol (2010) 1.50
Rapid relapse generally follows treatment for substance use disorders among adolescents. Addict Behav (2003) 1.48
Reliability and validity of the alcohol short index of problems and a newly constructed drug short index of problems. J Stud Alcohol Drugs (2009) 1.45
Predicting DSM-IV dependence diagnoses from Addiction Severity Index composite scores. J Subst Abuse Treat (2006) 1.38
A randomized clinical trial of alcohol care management delivered in Department of Veterans Affairs primary care clinics versus specialty addiction treatment. J Gen Intern Med (2013) 1.37
Conceptual, methodological, and analytical issues in the study of relapse. Clin Psychol Rev (2005) 1.30
The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study. Drug Alcohol Depend (2009) 1.30
Acceptability of audio computer-assisted self-interview (ACASI) among substance abusers seeking treatment in Rio de Janeiro, Brazil. Drug Alcohol Depend (2006) 1.28
Mediators of telephone-based continuing care for alcohol and cocaine dependence. J Consult Clin Psychol (2007) 1.19
Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence. J Subst Abuse Treat (2007) 1.18
A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Drug Alcohol Depend (2006) 1.17
Physical and sexual abuse, depression and alcohol use disorders in adolescents: onsets and outcomes. Drug Alcohol Depend (2003) 1.16
A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention. Alcohol Clin Exp Res (2008) 1.15
A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence. Addict Behav (2007) 1.11
Prevalence of DSM-IV and DSM-5 alcohol, cocaine, opioid, and cannabis use disorders in a largely substance dependent sample. Drug Alcohol Depend (2012) 1.10
A double-blind, placebo-controlled trial of modafinil for cocaine dependence. J Subst Abuse Treat (2012) 1.10
A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism. J Clin Psychopharmacol (2007) 1.10
Childhood abuse as a risk factor for suicidal behavior in borderline personality disorder. J Pers Disord (2002) 1.07
Recent status scores for version 6 of the Addiction Severity Index (ASI-6). Addiction (2011) 1.04
Identification of Multivariate Responders/Non-Responders Using Bayesian Growth Curve Latent Class Models. J R Stat Soc Ser C Appl Stat (2009) 1.04
Elevated substance P levels in HIV-infected women in comparison to HIV-negative women. AIDS Res Hum Retroviruses (2008) 1.04
Individual characteristics of the literally homeless, marginally housed, and impoverished in a US substance abuse treatment-seeking sample. Soc Psychiatry Psychiatr Epidemiol (2008) 1.04
Initial reliability and validity studies of the revised Treatment Services Review (TSR-6). Drug Alcohol Depend (2007) 1.04
Do patient characteristics and initial progress in treatment moderate the effectiveness of telephone-based continuing care for substance use disorders? Addiction (2005) 1.03
A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence. Drug Alcohol Depend (2013) 1.03
Early abstinence in cocaine pharmacotherapy trials predicts successful treatment outcomes. J Subst Abuse Treat (2009) 1.03
Accumbal neural responses during the initiation and maintenance of intravenous cocaine self-administration. J Neurophysiol (2003) 1.01
An examination of potential sex and race effects in a study of continuing care for alcohol- and cocaine-dependent patients. Alcohol Clin Exp Res (2003) 1.01
Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome. Biol Psychiatry (2007) 1.00
Alcohol relapse as a function of relapse definition in a clinical sample of adolescents. Addict Behav (2003) 0.99
Association between alcohol use and HIV viral load. J Acquir Immune Defic Syndr (2011) 0.99
Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy. Alcohol Clin Exp Res (2004) 0.99
A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers. Subst Abus (2012) 0.97
Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm. Psychopharmacology (Berl) (2005) 0.97
An adaptive approach for identifying cocaine dependent patients who benefit from extended continuing care. J Consult Clin Psychol (2013) 0.97
Psychiatric and substance use disorders as risk factors for attempted suicide among adolescents: a case control study. Suicide Life Threat Behav (2002) 0.95
Content matters: neuroimaging investigation of brain and behavioral impact of televised anti-tobacco public service announcements. J Neurosci (2013) 0.95
Accumbal neurons that are activated during cocaine self-administration are spared from inhibitory effects of repeated cocaine self-administration. Neuropsychopharmacology (2006) 0.95
A randomized trial of oral naltrexone for treating opioid-dependent offenders. Am J Addict (2010) 0.94
Family functioning and peer affiliation in children of fathers with antisocial personality disorder and substance dependence: associations with problem behaviors. Am J Psychiatry (2002) 0.94
Randomized trial of continuing care enhancements for cocaine-dependent patients following initial engagement. J Consult Clin Psychol (2010) 0.93
Maximum likelihood estimation with binary-data regression models: small-sample and large-sample features. Adv Appl Stat (2010) 0.93
Attention-deficit/hyperactivity disorder and conduct disorder symptomatology in adolescents with alcohol use disorder. Psychol Addict Behav (2002) 0.92
Genetic correlations between smoking initiation and smoking behaviors in a twin sample. Addict Behav (2006) 0.91
Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence. Drug Alcohol Depend (2013) 0.91
Comparison of embedded and isolated administrations of the California Psychological Inventory's Socialization subscale. Psychol Assess (2003) 0.90
A matched comparison study of medical and psychiatric complications and anesthesia and analgesia requirements in methadone-maintained liver transplant recipients. Liver Transpl (2004) 0.89
Sexual and physical victimization as predictors of HIV risk among felony drug offenders. AIDS Behav (2005) 0.88
Results of an initial clinical trial of varenicline for the treatment of cocaine dependence. Drug Alcohol Depend (2011) 0.86
Selective serotonin re-uptake inhibitors and the risk of bleeding. Expert Opin Drug Saf (2005) 0.85
Extended-release naltrexone modulates brain response to drug cues in abstinent heroin-dependent patients. Addict Biol (2012) 0.85
Identifying risk factors for marijuana use among veterans affairs patients. J Addict Med (2010) 0.85
A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence. Addict Behav (2010) 0.85
A critical review of selective serotonin reuptake inhibitor-associated bleeding: balancing the risk of treating hepatitis C-infected patients. J Clin Psychiatry (2003) 0.84
Examining naltrexone and alcohol effects in a minority population: results from an initial human laboratory study. Am J Addict (2011) 0.84
Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence. Addict Behav (2009) 0.83
A pilot trial of olanzapine for the treatment of cocaine dependence. Drug Alcohol Depend (2003) 0.83
Alcohol dependence and abuse in three groups at varying familial alcoholism risk. J Consult Clin Psychol (2002) 0.82
Relationship of Mental Health and Illness in Substance Abuse Patients. Pers Individ Dif (2010) 0.81
The role of family history in addiction severity and treatment response. J Subst Abuse Treat (2004) 0.81
Treatment services received in the CASAWORKS for Families program. Eval Rev (2003) 0.81
Addiction Severity Index (ASI) summary scores: comparison of the Recent Status Scores of the ASI-6 and the Composite Scores of the ASI-5. J Subst Abuse Treat (2013) 0.79
Measurement of mental health in substance use disorder outpatients. J Subst Abuse Treat (2010) 0.79
Characteristics and 9-month outcomes of discharged methadone maintenance clients. J Subst Abuse Treat (2010) 0.78
Does mandating offenders to treatment improve completion rates? J Subst Abuse Treat (2012) 0.78
Performance contracting to engage detoxification-only patients into continued rehabilitation. J Subst Abuse Treat (2010) 0.78
Affiliation with deviant peers among children of substance dependent fathers from pre-adolescence into adolescence: associations with problem behaviors. Drug Alcohol Depend (2003) 0.78
The prediction of violent and nonviolent criminal behavior in a methadone maintenance population. J Pers Disord (2002) 0.77
Racial disparities in hospitalized elderly patients with chronic heart failure. J Transcult Nurs (2004) 0.77
Tom Ten Have's contributions to causal inference and biostatistics: review and future research directions. Stat Med (2012) 0.77
Enhanced continuing care provided in parallel to intensive outpatient treatment does not improve outcomes for patients with cocaine dependence. J Stud Alcohol Drugs (2013) 0.77
Can we design and replicate clinical trials with a multiple drug focus. Drug Alcohol Depend (2003) 0.77
Neurokinin-1 receptor mRNA expression differences in brains of HIV-infected individuals. J Neurol Sci (2008) 0.77
A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependence. Am J Addict (2014) 0.76
Bayesian multivariate growth curve latent class models for mixed outcomes. Stat Med (2012) 0.75
Study blinding and correlations between perceived group assignment and outcome in a cocaine pharmacotherapy trial. Am J Addict (2008) 0.75
Social network correlates of participation in telephone continuing care for alcohol dependence. Am J Addict (2014) 0.75